These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 26000118)

  • 1. Pathophysiology of the antiphospholipid antibody syndrome.
    Willis R; Pierangeli SS
    Auto Immun Highlights; 2011 Nov; 2(2):35-52. PubMed ID: 26000118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The journey of antiphospholipid antibodies from cellular activation to antiphospholipid syndrome.
    Willis R; Gonzalez EB; Brasier AR
    Curr Rheumatol Rep; 2015 Mar; 17(3):16. PubMed ID: 25761923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of the antiphospholipid syndrome.
    Willis R; Harris EN; Pierangeli SS
    Semin Thromb Hemost; 2012 Jun; 38(4):305-21. PubMed ID: 22510982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid syndrome, "the best prophet of the future".
    Amengual O; Atsumi T
    Mod Rheumatol; 2018 May; 28(3):409-416. PubMed ID: 29385876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antiphospholipid syndrome: from pathophysiology to treatment.
    Negrini S; Pappalardo F; Murdaca G; Indiveri F; Puppo F
    Clin Exp Med; 2017 Aug; 17(3):257-267. PubMed ID: 27334977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome.
    Forastiero R; Martinuzzo M
    Expert Rev Clin Immunol; 2015; 11(11):1255-63. PubMed ID: 26295486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches.
    Lopez-Pedrera C; Barbarroja N; Patiño-Trives AM; Collantes E; Aguirre MA; Perez-Sanchez C
    Front Immunol; 2019; 10():764. PubMed ID: 31040845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
    Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
    Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay.
    Sciascia S; Baldovino S; Schreiber K; Solfietti L; Radin M; Cuadrado MJ; Menegatti E; Erkan D; Roccatello D
    Clin Mol Allergy; 2016; 14():6. PubMed ID: 27429595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple antiphospholipid antibodies positivity and antiphospholipid syndrome criteria re-evaluation.
    Forastiero R
    Lupus; 2014 Oct; 23(12):1252-4. PubMed ID: 25228718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing antiphospholipid syndrome in pregnancy.
    Schreiber K; Hunt BJ
    Thromb Res; 2019 Sep; 181 Suppl 1():S41-S46. PubMed ID: 31477227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement in the Pathophysiology of the Antiphospholipid Syndrome.
    Chaturvedi S; Brodsky RA; McCrae KR
    Front Immunol; 2019; 10():449. PubMed ID: 30923524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiphospholipid syndrome: still an enigma.
    Chaturvedi S; McCrae KR
    Hematology Am Soc Hematol Educ Program; 2015; 2015():53-60. PubMed ID: 26637701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
    Marai I; Levi Y; Godard G; Shoenfeld Y
    Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome.
    Breen KA; Seed P; Parmar K; Moore GW; Stuart-Smith SE; Hunt BJ
    Thromb Haemost; 2012 Mar; 107(3):423-9. PubMed ID: 22234447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelets and Thrombotic Antiphospholipid Syndrome.
    Tohidi-Esfahani I; Mittal P; Isenberg D; Cohen H; Efthymiou M
    J Clin Med; 2024 Jan; 13(3):. PubMed ID: 38337435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid antibody-mediated effects in an arterial model of thrombosis are dependent on Toll-like receptor 4.
    Laplante P; Fuentes R; Salem D; Subang R; Gillis MA; Hachem A; Farhat N; Qureshi ST; Fletcher CA; Roubey RA; Merhi Y; Thorin É; Levine JS; Mackman N; Rauch J
    Lupus; 2016 Feb; 25(2):162-76. PubMed ID: 26391610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.